Actinium to Showcase First-In-Class Targeted Radiotherapies in …?

Actinium to Showcase First-In-Class Targeted Radiotherapies in …?

WebActinium Pharmaceuticals, Inc. (ATNM) NYSE American - NYSE American Delayed Price. Currency in USD. Add to watchlist. 9.08-0.26 (-2.78%) At close: 04:00PM EDT. 9.40 … WebATNM Stock Price - Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody … crosley cd truck for sale WebSep 22, 2024 · 8. Actinium Pharmaceuticals. ♦. Academic clinical data with bismuth-213. −. 46 minute half life not amenable to development by industry. −. Phase 1 single agent study in relapsed/refractory AML WebDec 8, 2024 · Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients ... crosley cemetery WebNov 21, 2024 · Real-time trade and investing ideas on Actinium Pharmaceuticals Inc ATNM from the largest community of traders and investors. ... Not an offer or recommendation by Stocktwits. See disclosure here. Actinium Pharmaceuticals Inc NYSEMkt Updated Nov 21, 2024 11:34 PM. ATNM 11.78 0.15 (1.26%) Post-Market 0.44 … WebFind out all the key statistics for Actinium Pharmaceuticals, Inc. (ATNM), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ceo by dagrin WebMar 17, 2024 · JonesTrading analyst Justin Walsh maintained a Buy rating on Actinium Pharmaceuticals (ATNM - Research Report) today and set a price target of $24.00. The …

Post Opinion